FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kerstin Stenson

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Tanguy Seiwert; Kerstin M Stenson; V Villaflor; E A Blair; E E W Cohen; T Darga; Daniel J Haraf; M W Lingen; Joseph K Salama; R R Weichselbaum; Mary Ellyn Witt; E E Vokes
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
D W Golden; E Blair; E E W Cohen; T Nwizu; S Rudra; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Daniel J Haraf
Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.
Kent W Mouw; Elizabeth A Blair; Ezra E W Cohen; Daniel J Haraf; Marcy A List; Abhishek A Solanki; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Joseph K Salama
Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kerstin Stenson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tanguy Seiwert; Kerstin M Stenson; V Villaflor; E A Blair; E E W Cohen; T Darga; Daniel J Haraf; M W Lingen; Joseph K Salama; R R Weichselbaum; Mary Ellyn Witt; E E Vokes
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(3):769-76.
2013: D W Golden; E Blair; E E W Cohen; T Nwizu; S Rudra; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Daniel J Haraf
Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.
Oral oncology 2013;49(3):277-82.
2012: Kent W Mouw; Elizabeth A Blair; Ezra E W Cohen; Daniel J Haraf; Marcy A List; Abhishek A Solanki; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Joseph K Salama
Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.
Oral oncology 2012;48(10):1025-30.
2012: Cesar A Perez; Luis E Raez; Tanguy Y Seiwert; Hunho Song; Kerstin M Stenson; Everett E Vokes; Mark Agulnik; Elizabeth A Blair; Allison Dekker; Tatyana A Grushko; Olufunmilayo I Olopade; Ezra E W Cohen
Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck.
Oral oncology 2012;48(9):887-92.
2012: Kerstin M Stenson; Victoria Villaflor; Ezra E W Cohen; Elizabeth Blair; Daniel J Haraf; Rangesh Kunnavakkam; Ellen MacCracken; Louis D Portugal; Joseph K Salama; Tanguy Seiwert; Everett E Vokes
Chemoradiation for patients with large-volume laryngeal cancers.
Head & neck 2012;34(8):1162-7.
2012: Jonas A de Souza; Arun Khattri; Mark F. Kozloff; Rangesh Kunnavakkam; Mark W Lingen; Sreenivasa Nattam; Tanguy Seiwert; Kerstin M Stenson; Everett E Vokes; Stuart J Wong; Yujian Zhang; Serdal Aktolga; Elizabeth A Blair; Jeffrey Bozeman; Janet E Dancey; Darren W Davis; Ezra E W Cohen
A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(8):2336-43.
2011: V M Villaflor; Everett E Vokes; R D Williams; Mary Ellyn Witt; P Beniwal; E A Blair; A J Dekker; G Gomez-Abuin; Daniel J Haraf; Masha Kocherginsky; Alexander Langerman; Louis Portugal; Joseph K Salama; Tanguy Seiwert; Kerstin M Stenson; Ezra E W Cohen
Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(11):2501-7.
2011: Kevin S Choe; Ezra E W Cohen; Daniel J Haraf; Louis Portugal; Tanguy Y Seiwert; Abhishek Solanki; Kerstin M Stenson; Victoria M Villaflor; Everett E Vokes; Mary Ellyn Witt; Elizabeth A Blair; Joseph K Salama
Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Cancer 2011;117(20):4671-8.
2011: Joseph K Salama; Tanguy Seiwert; Kerstin M Stenson; E A Blair; Ezra E W Cohen; Daniel J Haraf; R Kunnavakkam; R Williams; Mary Ellyn Witt; Everett E Vokes
A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(10):2304-9.
2011: Aaron W Pederson; Joseph K Salama; Kerstin M Stenson; Everett E Vokes; Mary Ellyn Witt; Elizabeth A Blair; Daniel J Haraf
Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.
American journal of clinical oncology 2011;34(4):356-61.
2011: Aaron W Pederson; Louis Portugal; Joseph K Salama; Tanguy Seiwert; Kerstin M Stenson; Victoria M Villaflor; Everett E Vokes; Mary Ellyn Witt; Ezra E W Cohen; Daniel J Haraf; Elizabeth A Blair
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.
Head & neck oncology 2011;3():31.
2010: Aaron W Pederson; Daniel J Haraf; Mary Ellyn Witt; Kerstin M Stenson; Everett E Vokes; Elizabeth A Blair; Joseph K Salama
Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.
Head & neck 2010;32(11):1519-27.
2010: Ezra E W Cohen; Daniel J Haraf; Rangesh Kunnavakkam; Kerstin M Stenson; Elizabeth A Blair; Bruce E Brockstein; Eric P Lester; Joseph K Salama; Allison Dekker; Rosalyn Williams; Mary Ellyn Witt; Tatyana A Grushko; James J Dignam; Mark W Lingen; Olufunmilayo I Olopade; Everett E Vokes
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3336-43.
2010: Aaron W Pederson; Daniel J Haraf; Elizabeth A Blair; Kerstin M Stenson; Mary Ellyn Witt; Everett E Vokes; Joseph K Salama
Chemoreirradiation for recurrent salivary gland malignancies.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;95(3):308-11.
2010: Kerstin M Stenson; Rangesh Kunnavakkam; Ezra E W Cohen; Louis D Portugal; Elizabeth Blair; Daniel J Haraf; Joseph K Salama; Everett E Vokes
Chemoradiation for patients with advanced oral cavity cancer.
The Laryngoscope 2010;120(1):93-9.
2009: Alexander Langerman; Colleen Plein; Everett E Vokes; Joseph K Salama; Daniel J Haraf; Elizabeth A Blair; Kerstin M Stenson
Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer.
Archives of otolaryngology--head & neck surgery 2009;135(11):1133-6.
2009: Alexander Langerman; Richard Comstock; Sheela Konda; Anna Abramovitch; Kristen Kasza; Everett E Vokes; Kerstin M Stenson
Neck dissection planning based on postchemoradiation computed tomography in patients with head and neck cancer.
Archives of otolaryngology--head & neck surgery 2009;135(9):876-80.
2009: Ezra E W Cohen; Joshua Baru; Dezheng Huo; Daniel J Haraf; Maureen Crowley; Mary Ellyn Witt; Elizabeth A Blair; Ralph R Weichselbaum; Fred Rosen; Everett E Vokes; Kerstin M Stenson
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
Head & neck 2009;31(8):1013-21.
2009: Ezra E W Cohen; Darren W Davis; Theodore G Karrison; Tanguy Seiwert; Stuart J Wong; Sreenivasa Nattam; Mark F. Kozloff; Joseph I Clark; Duen-Hwa Yan; Wen Liu; Carolyn Pierce; Janet E Dancey; Kerstin M Stenson; Elizabeth Blair; Allison Dekker; Everett E Vokes
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
The lancet oncology 2009;10(3):247-57.
2008: Joseph K Salama; Kerstin M Stenson; Marcy A List; Loren K Mell; Ellen MacCracken; Ezra E W Cohen; Elizabeth Blair; Everett E Vokes; Daniel J Haraf
Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Archives of otolaryngology--head & neck surgery 2008;134(10):1060-5.
2008: Joseph K Salama; Kerstin M Stenson; Emily O Kistner; Bharat B Mittal; Athanassios Argiris; Mary Ellyn Witt; Fred R Rosen; Bruce E Brockstein; Ezra E W Cohen; Daniel J Haraf; Everett E Vokes
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levels.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(10):1787-94.
2008: B R Knab; Joseph K Salama; A Solanki; Kerstin M Stenson; Ezra E W Cohen; Mary Ellyn Witt; Daniel J Haraf; Everett E Vokes
Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(9):1650-4.
2008: Alvin B Cohn; Patrick O Lang; Jayant P Agarwal; Stephanie L Peng; Kaveh Alizadeh; Kerstin M Stenson; Daniel J Haraf; Ezra E W Cohen; Everett E Vokes; Lawrence J Gottlieb
Free-flap reconstruction in the doubly irradiated patient population.
Plastic and reconstructive surgery 2008;122(1):125-32.
2008: Tanguy Seiwert; Daniel J Haraf; Ezra E W Cohen; Kerstin M Stenson; Mary Ellyn Witt; Allison Dekker; Masha Kocherginsky; Ralph R Weichselbaum; Helen X Chen; Everett E Vokes
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1732-41.
2008: Joyce K Aycock; Kerstin M Stenson; Lawrence J Gottlieb
The thoracoacromial trunk: alternative recipient vessels in reoperative head and neck reconstructive microsurgery.
Plastic and reconstructive surgery 2008;121(1):88-94.
2007: Alexander Langerman; Ellen MacCracken; Kristen Kasza; Daniel J Haraf; Everett E Vokes; Kerstin M Stenson
Aspiration in chemoradiated patients with head and neck cancer.
Archives of otolaryngology--head & neck surgery 2007;133(12):1289-95.
2007: Tanguy Seiwert; Ezra E W Cohen; Daniel J Haraf; Kerstin M Stenson; Elizabeth A Blair; Ann M Mauer; Allison Dekker; Everett E Vokes
A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.
Cancer investigation 2007;25(6):435-44.
2006: Ezra E W Cohen; Daniel J Haraf; Marcy A List; Masha Kocherginsky; Bharat B Mittal; Fred R Rosen; Bruce E Brockstein; Rosalyn Williams; Mary Ellyn Witt; Kerstin M Stenson; Merrill S Kies; Everett E Vokes
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3438-44.
2006: Michael T Milano; Everett E Vokes; Johnny Kao; Wells Jackson; Marcy A List; Kerstin M Stenson; Mary Ellyn Witt; Allison Dekker; Ellen MacCracken; Michael C Garofalo; Steven J Chmura; Ralph R Weichselbaum; Daniel J Haraf
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
International journal of oncology 2006;28(5):1141-51.
2006: Jayant P Agarwal; Kerstin M Stenson; Lawrence J Gottlieb
A simplified design of a dual island fasciocutaneous free flap for simultaneous pharyngoesophageal and anterior neck reconstruction.
Journal of reconstructive microsurgery 2006;22(2):105-12.
2006: Joseph K Salama; Everett E Vokes; Steven J Chmura; Michael T Milano; Johnny Kao; Kerstin M Stenson; Mary Ellyn Witt; Daniel J Haraf
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
International journal of radiation oncology, biology, physics 2006;64(2):382-91.
2006: Kerstin M Stenson; Dezheng Huo; Elizabeth Blair; Ezra E W Cohen; Athanassios Argiris; Daniel J Haraf; E Everett Vokes
Planned post-chemoradiation neck dissection: significance of radiation dose.
The Laryngoscope 2006;116(1):33-6.
2005: Michael T Milano; Everett E Vokes; Joseph K Salama; Kerstin M Stenson; Johnny Kao; Mary Ellyn Witt; Bharat B Mittal; Athanassios Argiris; Ralph R Weichselbaum; Daniel J Haraf
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
International journal of radiation oncology, biology, physics 2005;61(4):1096-106.
2005: Joseph K Salama; Daniel J Haraf; Kerstin M Stenson; Michael T Milano; Mary Ellyn Witt; Everett E Vokes
Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer.
Cancer journal (Sudbury, Mass.) 2005;11(2):140-6.
2004: Michael T Milano; Daniel J Haraf; Kerstin M Stenson; Mary Ellyn Witt; Cathy Eng; Bharat B Mittal; Athanassios Argiris; Harold Pelzer; Mark F. Kozloff; Everett E Vokes
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(15):4922-32.
2004: Bruce E Brockstein; Daniel J Haraf; Alfred W Rademaker; Merrill S Kies; Kerstin M Stenson; Fred R Rosen; Bharat B Mittal; Harold Pelzer; B B Fung; Mary Ellyn Witt; Barry L Wenig; Louis Portugal; R W Weichselbaum; Everett E Vokes
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1179-86.
2004: Athanassios Argiris; Kerstin M Stenson; Bruce E Brockstein; Bharat B Mittal; Harold Pelzer; Merrill S Kies; Prathima Jayaram; Louis Portugal; Barry L Wenig; Fred R Rosen; Daniel J Haraf; Everett E Vokes
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Head & neck 2004;26(5):447-55.
2004: Athanassios Argiris; Bruce E Brockstein; Daniel J Haraf; Kerstin M Stenson; Bharat B Mittal; Merrill S Kies; Fred R Rosen; Borko Jovanovic; Everett E Vokes
Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1956-62.
2003: Charles Rudin; Ezra E W Cohen; Vassiliki A Papadimitrakopoulou; Sol Silverman; Wendy Recant; Adel K El-Naggar; Kerstin M Stenson; Scott M Lippman; Waun Ki Hong; Everett E Vokes
An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4546-52.
2003: Daniel J Haraf; Fred R Rosen; Kerstin M Stenson; Athanassios Argiris; Bharat B Mittal; Mary Ellyn Witt; Bruce E Brockstein; Marcy A List; Louis Portugal; Harold Pelzer; Ralph R Weichselbaum; Everett E Vokes
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5936-43.
2003: Everett E Vokes; Kerstin M Stenson
Therapeutic options for laryngeal cancer.
The New England journal of medicine 2003;349(22):2087-9.
2003: Elizabeth B Lamont; Davinder Hayreh; Kate E Pickett; James J Dignam; Marcy A List; Kerstin M Stenson; Daniel J Haraf; Bruce E Brockstein; Sarah A Sellergren; Everett E Vokes
Is patient travel distance associated with survival on phase II clinical trials in oncology?
Journal of the National Cancer Institute 2003;95(18):1370-5.
2003: Athanassios Argiris; S M Smith; Kerstin M Stenson; Bharat B Mittal; Harold Pelzer; Merrill S Kies; Daniel J Haraf; E E Vokes
Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1306-11.
2003: Ezra E W Cohen; Fred R Rosen; Walter M Stadler; Wendy Recant; Kerstin M Stenson; Dezheng Huo; Everett E Vokes
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(10):1980-7.
2003: Fred R Rosen; Daniel J Haraf; Merrill S Kies; Kerstin M Stenson; Louis Portugal; Marcy A List; Bruce E Brockstein; Bharat B Mittal; Alfred W Rademaker; Mary Ellyn Witt; Harold Pelzer; Ralph R Weichselbaum; Everett E Vokes
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1689-97.
2003: Samantha M Mucha; Kerstin M Stenson; Wendy Recant; Robert M Naclerio
Radiology quiz case 2. Verrucous carcinoma of the maxillary antrum.
Archives of otolaryngology--head & neck surgery 2003;129(2):259, 260-1.
2003: Everett E Vokes; Kerstin M Stenson; Fred R Rosen; Merrill S Kies; Alfred W Rademaker; Mary Ellyn Witt; Bruce E Brockstein; Marcy A List; Bing Bing Fung; Louis Portugal; Bharat B Mittal; Harold Pelzer; Ralph R Weichselbaum; Daniel J Haraf
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):320-6.
2001: Merrill S Kies; Daniel J Haraf; Fred R Rosen; Kerstin M Stenson; Marcy A List; Bruce E Brockstein; T Chung; Bharat B Mittal; Harold Pelzer; Louis Portugal; Alfred Rademaker; R Weichselbaum; Everett E Vokes
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1961-9.
2001: CA Mantz; Everett E Vokes; Kerstin M Stenson; Merrill S Kies; B Mittal; Mary Ellyn Witt; Marcy A List; Ralph R Weichselbaum; Daniel J Haraf
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
Cancer journal (Sudbury, Mass.) 2001;7(2):140-8.
2000: Kerstin M Stenson; Daniel J Haraf; Harold Pelzer; Wendy Recant; Merrill S Kies; Ralph R Weichselbaum; Everett E Vokes
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection.
Archives of otolaryngology--head & neck surgery 2000;126(8):950-6.
2000: Bruce E Brockstein; Daniel J Haraf; Kerstin M Stenson; L Sulzen; Mary Ellyn Witt; R W Weichselbaum; Everett E Vokes
A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):721-8.
2000: Everett E Vokes; Merrill S Kies; Daniel J Haraf; Kerstin M Stenson; Marcy A List; Rod A Humerickhouse; M Eileen Dolan; Harold Pelzer; L Sulzen; Mary Ellyn Witt; Y C Hsieh; Bharat B Mittal; Ralph R Weichselbaum
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1652-61.
2000: Kerstin M Stenson; Ellen MacCracken; Marcy A List; Daniel J Haraf; Bruce E Brockstein; R Weichselbaum; Everett E Vokes
Swallowing function in patients with head and neck cancer prior to treatment.
Archives of otolaryngology--head & neck surgery 2000;126(3):371-7.
1999: Helen M Sharp; Marcy A List; Ellen MacCracken; Kerstin M Stenson; CB Stocking; M Siegler
Patients' priorities among treatment effects in head and neck cancer: evaluation of a new assessment tool.
Head & neck 1999;21(6):538-46.
1999: Marcy A List; Amy K Siston; Daniel J Haraf; Phil L Schumm; Merrill S Kies; Kerstin M Stenson; Everett E Vokes
Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):1020-8.
1999: Daniel J Haraf; Merrill S Kies; Alfred W Rademaker; Kerstin M Stenson; B Mittal; Harold Pelzer; Barry L Wenig; Mary Ellyn Witt; L Sulzen; Ralph R Weichselbaum; Everett E Vokes
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):638-44.
1999: Rod A Humerickhouse; M Eileen Dolan; Daniel J Haraf; Bruce E Brockstein; Kerstin M Stenson; Merrill S Kies; L Sulzen; Mark J Ratain; Everett E Vokes
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):291-8.
1998: Bruce E Brockstein; Daniel J Haraf; Kerstin M Stenson; AA Fasanmade; R Stupp; B Glisson; S M Lippman; Mark J Ratain; L Sulzen; A Klepsch; Ralph R Weichselbaum; Everett E Vokes
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):735-44.
1997: Kerstin M Stenson; James M Balter; J H Campbell; W R Carroll
Effects of implantable biomaterials on radiation dosimetry.
Head & neck 1997;19(5):384-90.
1997: Daniel J Haraf; Kerstin M Stenson; Marcy A List; Mary Ellyn Witt; Ralph R Weichselbaum; Everett E Vokes
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer.
Seminars in oncology 1997;24(1 Suppl 2):S2-68-S2-71.
1995: Everett E Vokes; Daniel J Haraf; Kerstin M Stenson; R Stupp; D Malone; J Levin; Ralph R Weichselbaum
The role of paclitaxel in the treatment of head and neck cancer.
Seminars in oncology 1995;22(5 Suppl 12):8-12.